EPIDEMIOLOGY OF JAPANESE ENCEPHALITIS AND CONTROL MEASURES - PowerPoint PPT Presentation

1 / 48
About This Presentation
Title:

EPIDEMIOLOGY OF JAPANESE ENCEPHALITIS AND CONTROL MEASURES

Description:

If survive the patient will be with severed physical and neurological complications. ... virus was isolated for the first time in the world from a post-mortem ... – PowerPoint PPT presentation

Number of Views:280
Avg rating:3.0/5.0
Slides: 49
Provided by: Selva5
Category:

less

Transcript and Presenter's Notes

Title: EPIDEMIOLOGY OF JAPANESE ENCEPHALITIS AND CONTROL MEASURES


1
EPIDEMIOLOGY OF JAPANESE ENCEPHALITIS AND CONTROL
MEASURES
Dr.I.Selvaraj, I.R.M.S B.SC., M.B.B.S., ( M. D
COMMUNITY MEDICINE )., D.P.H., D.I.H., P.G.C.H
FW (NIHFW, NEW DELHI) Sr.D.M.O (ON STUDY
LEAVE) INDIAN RAILWAY MEDICAL SERVICE
2
(No Transcript)
3
Seen in picture is a man rushing his child to
a hospital in Ghorakpur, Uttar Pradesh.)
4
Doctors look at a child who is being treated for
Japanese Encephalitis at a hospital in Lucknow,
India, Thursday, Sept. 8, 2005. The
death toll from an outbreak of Japanese
Encephalitis in northern India has reached nearly
600, as another 53 people died overnight.
5
  • Japanese Encephalitis is a viral zoonotic disease
    of Public health importance, because of its
    epidemic potential and high case
    mortality rate. 
  • It is a mosquito borne zoonotic disease.  
  • The virus infects mainly animals through
    migrating birds.  Pig is the amplifier host. 
    Man is affected incidentally.  
  • J.E. is primarily a disease of rural,semi urban,
    agricultural areas where vector mosquitoes
    proliferate in close association
    with pigs and other animal reservoirs. 
  • Man to man transmission is not possible. 
  • The detection of cases are difficult due to the
    disease apparent and in apparent nature.
  • Once the human is infected with the disease it
    leads to death in most of the
    cases. 
  • If survive the patient will be with severed
    physical and neurological complications.

6
(No Transcript)
7
Japanese Encephalitis is a mosquito-borne viral
infection that occurs chiefly in three areas (1)
China and Korea, (2) the Indian sub-continent
consisting of India, parts of Bangladesh,
southern Nepal, and Sri Lanka, and (3) the
southeast Asian countries of Burma, Thailand,
Cambodia, Laos, Vietnam, Malaysia, Indonesia and
the Philippines. Japanese Encephalitis also may
occur with a lower frequency in Japan, Taiwan,
Singapore, Hong Kong, and eastern Russia.
8
  • The virus was isolated for the first time in the
    world from a post-mortem human brain in Japan in
    1933
  • JE was clinically diagnosed for the first time in
    India in 1955 at Vellore, erstwhile North Arcot
    district of Tamil Nadu.
  • Approximately 3 billion people and 60 of the
    world's population live in endemic region
  • 50,000 cases with 10,000 deaths were notified
    annually from a wide geographic range.
  • In India there was a rise of JE incidence in
    1980s and has dropped significantly and
    maintained till 1995
  • . The major outbreaks coincided with the heavy
    rainfall and or floods.
  • In India, JE is considered mainly as a pediatric
    problem.

9
JE OUTBREAK INDIA
  • Nagpur (1954-1955)
  • North Arcot , Madras (1955)
  • Agra,U.P- 1958
  • W.Bengal 1973
  • TN, KA,WB,AP,Bihar,Assam,U.P-1977-1979
  • Goa, Kerala, Haryana (samuel et.al.2000) .
  • 1145 cases of Japanese encephalitis have been
    reported from 14 districts of Uttar Pradesh
    Province, India from 29 July to 30 August 2005.
    About one-fourth of these (n296) have died. 90
    cases from the adjoining districts of Bihar have
    also been admitted to the hospitals in Uttar
    Pradesh.

10
Children romp in a rice field near Rakshwapar
village in the northern Indian state of Uttar
Pradesh, a bowl-shaped breeding ground for
mosquitos that spread Japanese encephalitis.
This year has been exceptionally rainy, leaving
mosquito-friendly pools of water everywhere. At
least 850 people, mostly children, have already
died from the incurable disease.
11
AREA OF HIGH OCCURRENCE IN
INDIA
  • The three southern states of Tamil Nadu (TN),
    Andra Pradesh, Karnataka were reporting higher
    incidence.
  • JE is emerging as a public health problem in
    Kerala
  • In a few villages of Cuddalore district of Tamil
    Nadu, a known JE-endemic area (Chidambaram,
    Virudhachalam, Thittakudi)

12
(No Transcript)
13
(No Transcript)
14
TAMILNADU
  • In the early 80s cases were reported from
    Tamilnadu in the following revenue districts
    Tiruvannamalai, Dharmapuri, Namakkal,
    Trichirapalli, Dindigul, Theni,
    Madurai,Virdhunagar, Tirinelveli,  and Tuticorin.
  • However for the past 5 years sporadic cases are
    reported from Villupuram, Cuddalore,and
    Perambalur districts only.

15
Incidence of Japanese Encephalitis - Tamil Nadu
16
  • The viruses responsible for these diseases are
    classified as arbovirus and these diseases are
    collectively called as arbovirus encephalitis.
  • JEV is related to St. Louis encephalitis virus,
    Murray Valley virus and West Nile virus.
  • The virus is antigenically related to several
    other flaviviruses including dengue virus.
  • JE virus is a member of the family Flaviviridae.
  • I t is a single stranded RNA virus.
  • It has three proteins
  • A) envelope protein
  • B) core protein
  • C) membrane protein

17
(No Transcript)
18
Culex mosquito biting human.
19
FEMALECULEX QUINQUEFASCIATUS
20
Image Culex mosquito laying eggs.(Photograph by
Richard G. Weber)
21
(No Transcript)
22
VECTORS
  • JEV can be transmitted by mosquitoes in the
    genera Culex
  • major vectors for JEV transmission in India
    belong to Culex vishnui subgroup which comprises
    of Cx. pseudovishnui colles.
  • Though JEV has been isolated from 16 species of
    mosquitoes, the majority of the isolations are
    from Cx. vishnui complex, which breed extensively
    in rice eco system.
  • The disease occurrence coincide with the rainy
    season
  • The predominant mosquito species involved in JEV
    transmission breed in rice fields and water
    surfaces.
  • The birds (egrets, pond herons, paddy birds)
    which a have role in JEV transmission have close
    link with rice fields and water.
  • . Among the vertebrate hosts, though the cattle
    populations do not circulate the virus (dead
    end), they support the mosquito species by
    providing blood meal to them.
  • . Establishment of pig forms for economical
    reasons are related to human activities in the
    country side.
  • Building reservoirs and canals for agricultural
    purposes may harbor potentials for JEV
    transmission.

23
  • Cx. tritaeniorhynchus -TN, KA, KL
  • Cx. vishnui - TN, KA, WB
  • Cx. Pseudovishnui - KA, GOA
  • Cx. bitaeniorhynchus - KA, WB
  • Cx. epidesmus - WB
  • Cx. fuscocephala - TN, KA
  • Cx. gelidus - TN, KA
  • Cx. quinquefasciatus - KA
  • Cx. whitmorei - TN,KA, AP, WB
  • An. barbirostris - WB
  • An. paeditaeniatus - KA
  • An. Subpictus - TN, KA, KL
  • Ma. annulifera - KL, ASSAM
  • Ma. indiana - KL
  • Ma. uniformis - KA, KL

24
  • Man is an incidental and dead-end host.
  • Man-to-man transmission does not occur in nature.
  • Cattle also act as dead-end host in the
    transmission cycle.
  • From Ardeid birds, JE infection is transmitted
    by mosquitoes to pigs/ducklings.
  • The pigs/ducklings serve as amplifying hosts
    since thevirus multiplies in them.
  • . Man or cattle get infected either from birds or
    pigs/ducklings through mosquito bite.
  • . Ardeid birdmosquitoArdeid bird and
    pig/ducklingmosquitopig/duckling cycle exist in
    nature.

25
(No Transcript)
26
  • Transmission is usually seasonal
  • In temperate zones of China, Japan, Korea and
    northern areas of Southeast Asia, Japanese
    encephalitis is transmitted during summer and
    early autumn -- May to September.
  • In north India and Nepal transmission occurs
    from June to November
  • In south India and Sri Lanka epidemics are found
    from September to January.

27
  • The vast majority of JE infections are in
    apparent
  • only 1 in 250 infections results symptomatic
    illness
  • Most infected persons develop mild symptoms or no
    symptoms at all.
  • Symptoms soon after exposure appear 6-8 days
    after the bite of an infected mosquito.
  • The incubation period is about 5-15 days.
  • Extrinsic incubation period in vector mosquitoes
    is 9-12 days.
  • Approximately 25-30 of cases are fatal, some
    with a fulminate course lasting a few days and
    others run a more protracted course in coma.
  • . About 30 of those who survive may have
    sequelae.
  • Young children (under 10 years) are more likely
    to die, and if they survive, they are likely to
    have residual neurological disability and
    principal sequelae

28
(No Transcript)
29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
Differential Diagnosis
  • Cerebral Malaria
  • Meningitis
  • Febrile Convulsions
  • Reys Syndrome
  • Rabies
  • Toxic Encephalopathy

33
  • LABORATORY INVESTIGATION
  • Peripheral blood picture shows moderate
    peripheral leucocytosis with neurophilia and mild
    anemia.
  • CSF (cerbro spinal fluid) analysis Neutrophils
    may predominate in early CSF samples but a
    lymphocytic pleocytosis is typical.
  • CSF protein is moderately elevated in about 50
    of cases.
  • Serological tests These are to detect
    antibodies to viral antigens, which include the
    plaque reduction virus neutralization test,
    hemagglutination inhibition, and complement
    fixation. . A significant rise in titer should be
    seen with paired samples from the acute and
    convalescent stages.
  • The virus is isolated from CSF by inoculating
    into 2-4 day old mice and the virus is identified
    by haemagglutination inhibition. Japanese
    encephalitis virus may also be identified by
    infection of cell cultures (chicken embryo or
    hamster kidney cells, or the mosquito cell line
    C3/36) and by IFA.

34
DIAGNOSTIC FACILITIES TAMILNADU
  • Sera  are collected from the J.E. cases and sent
    to Virology department, Madurai Medical college
    (or) King Institute, Guindy, Chennai (or)
    Institute of Vector Control and Zoonoses, Hosur
    for Laboratory  diagnosis of J.E. case.
  • Vector mosquitoes collected from the field are
    sent to CRME, Madurai and Institute of Vector
    control and Zoonoses, Hosur for PCR analysis for
    detection of virus.

35
JE CASE CLASSIFICATION, NICD, NEW DELHI
  • SUSPECT A CASE THAT IS COMPATIBLE WITH THE
    CLINICAL DESCRIPTION
  • PROBABLE A SUSPECT CASE WITH PRESUMPTIVE
    LABORATORY RESULTS
  • CONFIRMED A SUSPECTED CASE THAT IS LABORATORY
    CONFIRMED

36
JE CONTROL STRATEGY
  • Early Case Detection and Treatment
  • Vector Control
  • A)REDUCTION OF BREEDING SOURCE FOR LARVAE
    B) REDUCTION IN MAN-MOSQUITO CONTACTC) CONTROL
    OF ADULT MOSQUITOES
  • . Prevention
  • A) JE VACCINATION

37
Reduction of Breeding Source for Larvae
  • They are water management system with
    intermittent irrigation system
  • incorporation of neem products in rice fields
  • The water management is nothing but a strategy of
    alternate drying and wetting water management
    system in the rice fields.
  • This can be implemented only with the
    co-ordination of the farmers.
  • Introduction of composite fish culture for
    mosquito control in rice fields have been
    evaluated and proved to be successful.

38
  • PIG CONTROL
  • segregation
  • slaughtering,
  • and vaccination
  • MOSQUITO CONTROL
  • spraying,
  • draining mosquito habitats,
  • or using bednets

39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
  • JE VACCINE
  • INACTIVATED MOUSE BRAIN VACCINE
  • It is expensive vaccine, complicated dosing
    schedule, side effect of this vaccine.
  • Inactivated Mouse brain vaccine
  • 3-5 US dollars/dose
  • 9 15 US dollars/per child
  • The mouse brain vaccine manufactured by killing
    populations of mice was being manufactured by
    Central Research Institute, Kasauli.
  • LIVE ATTENUATED VACCINE
  • SA 14 - 14-2 (Chinese live attenuated vaccine at
    affordable cost, safe, effective).
  • This vaccine was developed in China and has been
    used there since 1988.
  • it has been licensed and used in South Korea and
    Nepal and licensed in Sri Lanka.
  • It also appears feasible that a single dose of
    vaccine will provide life-long protection.

44
(No Transcript)
45
(No Transcript)
46
OTHER NEW VACCINE
  • A live, attenuated chimeric vaccine which uses
    a yellow fever vaccine virus strain as its
    backbone (ChimeriVax-JE, manufactured by
    Acambis).
  • Clinical trials also are underway for a JE
    vaccine candidate manufactured by Intercell.
    Following a successful Phase II study in the
    United States, Intercell initiated Phase III
    trials in September 2005 to test the vaccines
    safety and immunogenicity in nearly 5,000 adult
    subjects throughout the United States, Europe,
    and other countries. This vaccine is inactivated
    but does not require mouse brains for production.

47
RESEARCH PROJECT TAMILNADU In collaboration with
the public health department, the CRME, Madurai
is undertaking the impregnated curtains trials at
Sirimangalam and Nallur Primary Health Centres in
Cuddalaore district for control of J.E. vectors.
48
REFERENCE
  • http//www.path.org/projects/JE_in_depth.php
  • http//www.pon.nic.in/vcrc/jemanag.html
  • K.PARK
  • LECTURE NOTES ON MALARIA CONTROL AND OTHER VECTOR
    BORNE DISEASES, HOSUR
  • MANSONS TROPICAL DISEASES
  • JAPANESE ENCEPHALITIS GLOBALLY AND IN
    INDIA-INDIAN JOURNAL OF PUBLIC HEALTH
    VOL.XXXXVIII No.2APRIL-JUNE 2004
  • Japanese encephalitis in India An
    overviewKabilan Lalitha, Rajendran R,
    Arunachalam N, Ramesh S, Srinivasan S, Philip
    Samuel P, Dash APCentre for Research in Medical
    Entomology, Madurai, India
  • Year 2004    Volume 71    Issue 7 
      Page 609-615
Write a Comment
User Comments (0)
About PowerShow.com